हिंदी ▼
होम मध्यप्रदेश भारत ऑटोमोबाइल टेक्नोलॉजी खेल लाइफस्टाइल खेती
मेन्यू

टेक्नोलॉजी

मोबाइल AI गैजेट

Karen Friar

Sharp Sell-off Grips Dalal Street: BSE Sensex Plummets Nearly 1,000 Points

Mumbai: India’s benchmark stock index, the BSE SENSEX, faced intense selling pressure during trading hours on Thursday, April 4th. The index experienced a significant downturn, ...

Intel Appoints Lip-Bu Tan as CEO: A New Era for the Struggling Chip Giant?

Intel’s Leadership Shakeup: Lip-Bu Tan Takes the Helm After a turbulent few years, Intel has appointed Lip-Bu Tan as its new CEO in a ...

U.S. Stocks Slide as UnitedHealth Probe and Economic Woes Weigh on Markets

Wall Street Sees Red Amid UnitedHealth Investigation and Weak Economic Data U.S. stocks tumbled on Friday, with all three major indices heading for weekly ...

UnitedHealth Group (NYSE:UNH) Shares Plunge 7% Amid DOJ Fraud Investigation

DOJ Launches Civil Fraud Probe into UnitedHealth’s Medicare Advantage Practices Shares of UnitedHealth Group (NYSE:UNH) tumbled approximately 7% in premarket trading on Friday following ...

Wall Street Struggles for Direction Amid Walmart’s Outlook and UnitedHealth Investigation

Markets Mixed as Wall Street Recovers from Thursday’s Sell-Off Wall Street’s major indexes showed a mixed performance on Friday as investors attempted to regain ...

FDA Declares End to Semaglutide Shortage, Grants Grace Period for Compounders

FDA Ends GLP-1 Shortage, Pauses Enforcement Against Compounders The U.S. Food and Drug Administration (FDA) announced Friday that it will temporarily hold off on ...

Hims & Hers Acquires Peptide Facility Amid Weight Loss Drug Shift, Stock Drops 20%

Hims & Hers Health (NYSE: HIMS) has acquired a California-based peptide facility to strengthen its supply chain and expand its presence in the growing ...

FDA Declares End to Ozempic and Wegovy Shortages, Impacting Hims & Hers Health (NYSE:HIMS)

Novo Nordisk’s Ozempic and Wegovy No Longer in Short Supply, Creating Challenges for Hims & Hers The U.S. Food and Drug Administration (FDA) announced ...

Arbor Realty Trust (NYSE:ABR) Q4 2024 Earnings and Dividend Announcement

Arbor Realty Trust (NYSE:ABR) reported Q4 2024 earnings with lower-than-expected results, as EPS and revenue both came in below analyst estimates. Additionally, the company ...

Goldman Sachs Reveals Stocks with Biggest Short Interest Shifts Since U.S. Election

Goldman Sachs analysts have identified the stocks with the largest increases and decreases in short interest since the U.S. election day, shedding light on ...

Bluebird Bio (NASDAQ:BLUE) to Go Private in $3 Billion M&A Deal with Carlyle and SK Capital

Bluebird Bio Stock Crashes 37% as Carlyle and SK Capital Plan Takeover Shares of bluebird bio (NASDAQ:BLUE) plummeted ~37% in premarket trading on Friday ...

Apple (NASDAQ:AAPL) Removes Advanced Data Protection in the UK Amid Government Pressure

Apple (NASDAQ:AAPL) is withdrawing its Advanced Data Protection (ADP) feature for cloud data in the United Kingdom after facing government orders to create a ...

Coinbase (NASDAQ:COIN) Surges as SEC Agrees to Dismiss Lawsuit with No Fines

Coinbase CEO Brian Armstrong Announces Victory in SEC Legal Battle Shares of Coinbase (NASDAQ:COIN) climbed 2.4% in early Friday trading after CEO Brian Armstrong ...

Virtus InfraCap U.S. Preferred Stock ETF (NYSEARCA:PFFA) Declares $0.1700 Dividend for February 2024

PFFA Maintains Consistent Dividend Payout for Investors Virtus InfraCap U.S. Preferred Stock ETF (NYSEARCA:PFFA) has announced a monthly dividend of $0.1700 per share, continuing ...

Kenvue (NYSE:KVUE) Rises on Takeover Speculation Amid Activist Pressure

Kenvue Gains Amid Rumors of Acquisition Interest Shares of Kenvue (NYSE:KVUE), the consumer health company known for brands like Tylenol, surged by 2% following ...

Arbor Realty Trust (NYSE:ABR) Posts Mixed Q4 Results as Earnings Miss but NII Beats Estimates

Arbor Realty Trust Reports Q4 2024 Financial Results Arbor Realty Trust (NYSE:ABR) delivered a mixed performance in its Q4 2024 earnings report, with distributable ...

J.P. Morgan Upgrades Grab Holdings (GRAB) to Overweight, Sees Strong Earnings Growth Ahead

Grab Holdings (NASDAQ: GRAB) received a major boost from J.P. Morgan, which upgraded the stock to Overweight from Neutral, citing strong earnings potential, improved ...

Goldman Sachs Identifies Key Hedge Fund Shifts Following Post-Election Policies

Hedge Funds Reposition Portfolios Amidst Regulatory and Trade Policy Changes Goldman Sachs strategists have observed significant shifts in hedge fund positioning following policy changes ...

Arbor Realty Trust (NYSE:ABR) Q4 2024 Earnings: EPS and Revenue Fall Short of Expectations

Arbor Realty Trust (NYSE:ABR) reported Q4 2024 earnings with lower-than-expected results, as EPS and revenue both came in below analyst estimates. Earnings Overview Non-GAAP ...

Gilead Seladelpar Wins EU Approval for Rare Liver Disease Treatment

Gilead Sciences (NASDAQ: GILD) has secured conditional marketing authorization from the European Commission (EC) for seladelpar, a breakthrough treatment for primary biliary cholangitis (PBC), ...

1236 Next